Surmodics | SRDX - Ebitda


Surmodics reported $1.53M in EBITDA for its fiscal quarter ending in September of 2024.





Ebitda Change Date
Abbott USD 3.09B 44M Sep/2025
Align Technology USD 183.84M 19.77M Sep/2025
Anika Therapeutics USD -2.69M 4.73M Mar/2025
Arrowhead Research USD 64.2M 223.53M Sep/2025
Baxter International USD 462M 137M Jun/2025
Boston Scientific USD 1.37B 1000K Sep/2025
EDAP TMS EUR -5.77M 228K Jun/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Heron Therapeutics USD -3.88M 5.63M Sep/2024
J&J USD 9.52B 389M Sep/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Nektar Therapeutics USD -31.81M 70K Sep/2023
Option Care Health USD 119.5M 5.48M Sep/2025
Stryker USD 1.67B 206M Sep/2025
Surmodics USD 1.53M 485K Sep/2024
Trinity Biotech USD -9.6M 7.64M Dec/2024